Navigation Links
Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
Date:8/25/2009

uld have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

    CONTACT: Amgen, Thousand Oaks
    Emma Hurley: 805-447-7845 (media)
    Arvind Sood: 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
2. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
3. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
6. Medarex to Receive Milestone Payment from Amgen
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
10. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
11. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Mich. , Aug. 22, 2014  Dr. ... Who with the Diamond Lifetime Achievement Award in the ... as CEO of Cardiovascular Clinical Associates. Dr. ... in managing all major aspects of the business; overseeing ... well as primary coronary intervention. In addition, he is ...
(Date:8/22/2014)... , Aug. 22, 2014 MC Medical, a ... (MID), a Columbus, OH medical device ... the FloShield laparoscopic and robotic visualization system in ... approved for sale in Japan in ... long-time experience and an extensive product portfolio in endoscopic surgery ...
(Date:8/22/2014)... , Aug. 22, 2014 Research and ... "Global and Chinese Intravenous Catheter Industry Report 2014" ... and Chinese Intravenous Catheter Industry Report 2014 is a ... the global intravenous catheter industry with a focus on ... overview of the industry including definitions, classifications, applications and ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Global and Chinese Intravenous Catheter Industry Report 2014 2
... Fla., Aug. 11, 2011 China Nuvo Solar Energy, ... signed an agreement with Tandem Receivable Solutions to a ... Contracting Consultant, is committed to assisting the Company from ...   Tom Toland, CEO of SurgLine ...
... ChromaDex Corporation (OTCBB: CDXC), an innovative natural products ... to the dietary supplement, food & beverage, cosmetic ... the second quarter of 2011. On a reported ... Accepted Accounting Principles (U.S. GAAP), ChromaDex announced total ...
Cached Medicine Technology:China Nuvo Solar Target Acquisition SurgLine Announces Agreement With Western U.S. Distributor 2China Nuvo Solar Target Acquisition SurgLine Announces Agreement With Western U.S. Distributor 3ChromaDex Announces Financial Results for Second Quarter 2011 2ChromaDex Announces Financial Results for Second Quarter 2011 3ChromaDex Announces Financial Results for Second Quarter 2011 4
(Date:8/22/2014)... 22, 2014 For patients who need surgery for ... procedure is the least often used, reports a study ... , official journal of the Congress of Neurological ... Williams & Wilkins , a part of Wolters ... good pain relief at much lower cost than other ...
(Date:8/22/2014)... Ticket Down is a reliable source ... Orleans, Albuquerque and Rapid City. For fans looking to speak ... Caputo, allows just that. Caputo was born and raised in ... close knit family who began to see spirits when she ... she had a chance to do what most people wished ...
(Date:8/22/2014)... Pirate Jonny's Caribbean BBQ Rubs, ... new recipe cards, fun t-shirts, and caps for consumers ... Clearwater, Florida, Pirate Jonny, aka, Jonathan Toner, founder, decided ... to three recipes featuring different flavors of the Caribbean, ... website. The recipe cards will feature "easy to ...
(Date:8/22/2014)... According to the new research ... Global Trends & Forecast to 2019" defines and ... forecast of the market value. The isocyanate material ... 2019, at a significant CAGR from 2014 to ... 44 figures spread through 286 pages and in-depth ...
(Date:8/22/2014)... Society for Medical Oncology (ESMO), the leading pan-European ... names of three outstanding individuals receiving the Society,s ... to Carsten Bokemeyer, Heikki Joensuu and Peter Boyle ... 26-30 September, Madrid, Spain. , Carsten Bokemeyer will ... accelerate the transition of cancer discovery into real ...
Breaking Medicine News(10 mins):Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3
... Sharing a favorite ritual might ease a friend or family member,s ... member or friend is in the hospital over the holidays, you ... from home. , "Being in the hospital, away from family ... people," Denice Foose, a chaplain at The Methodist Hospital in Houston, ...
... be possible to grow human blood platelets in the ... The Ohio State University Medical Center. , The findings, ... journal Experimental Hematology , might one day enable ... that can ease the chronically tight supply of these ...
... J Lounge in downtown Los Angeles, on Friday, December 26th starting at ... Diamond Foundation, which was founded to assist people who need access to ... ... Boxer Manny Pacquiao, fresh off his victory against Oscar Dela Hoya in ...
... ingredients not listed on label , , MONDAY, Dec. 22 ... warned consumers Monday to avoid more than two dozen ... ingredients that could pose serious health risks. , The ... the Internet and some claim to contain only "natural" ...
... the way people around the world communicate and do business. ... to do the same thing for medicine. ... Aydogan Ozcan, a prototype cell phone has been constructed that ... patients, as well as testing water quality in undeveloped areas ...
... the animals from smoke,s harmful effects, researchers say , , ... mice, scientists have shown that a new drug may ... cigarettes. , The finding holds out hope for patients ... progressive lung disease involving both emphysema and chronic obstructive ...
Cached Medicine News:Health News:Take the Holiday to the Hospital 2Health News:Bioreactors might solve blood-platelet supply problems 2Health News:Pacquiao Hosts Post-Christmas/Post-Birthday Victory Celebration 2Health News:FDA Warns About Weight Loss Products 2Health News:FDA Warns About Weight Loss Products 3Health News:Cell phones using lens-free imaging promise to improve health monitoring 2Health News:Drug Shields Mice From Emphysema 2
The portable, cost-effective system designed for fast studies and bedside reporting. The size, features and cost make this a perfect unit for a new practice, or as a second or third unit for larger h...
BB Watchmaker Forceps, Pakistan, 4.5" fine point....
The vertebral body replacement (VBR) is used for the anterior thoracic and lumbar spine. It is intended for use in the thoracic and lumbar spine to replace a collapsed, damaged, or unstable vertebral...
Vertigraft femoral shaft an large femoral cross-section designed primarily for use in lumbar corpectomy procedures. Freeze dried preservation....
Medicine Products: